@misc{10481/88530,
year = {2014},
url = {https://hdl.handle.net/10481/88530},
abstract = {In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human leukocyte antigen (HLA) region were imputed and tested. These analyses resulted in a model composed of six polymorphic amino acid positions and seven SNPs that explained the observed significant associations in the region. In addition, a replication step comprising 4,017 SSc cases and 5,935 controls was carried out for several selected non-HLA variants, reaching a total of 5,850 cases and 9,401 controls of European ancestry. Following this strategy, we identified and validated three SSc risk loci, including DNASE1L3 at 3p14, the SCHIP1-IL12A locus at 3q25, and ATG5 at 6q21, as well as a suggested association of the TREH-DDX6 locus at 11q23. The associations of several previously reported SSc risk loci were validated and further refined, and the observed peak of association in PXK was related to DNASE1L3. Our study has increased the number of known genetic associations with SSc, provided further insight into the pleiotropic effects of shared autoimmune risk factors, and highlighted the power of dense mapping for detecting previously overlooked susceptibility loci.},
organization = {This study was supported by National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Dis-
eases (NIAMS) Centers of Research Translation (CORT) grant
P50AR054144, NIH grant KL2RR024149-04, NIH NIAMS grant
N01-AR02251, and NIH National Center for Research Resources
grant 3UL1RR024148. This study was supported by GEN-FER
from the Spanish Society of Rheumatology, SAF2009-11110 and
SAF2012-34435 from the Spanish Ministry of Science, CTS-4977
from Junta de Andalucia, and RD08/0075 and RD12/0009/0004
from the Redes Temáticas de Investigación Cooperativa en Salud
(Red de Investigación en Inflamación y Enfermedades Reumáti-
cas). We are indebted to the Immunochip Consortium for provi-
sion of the control data. We are grateful to Julio Charles, Marilyn
Perry, Suzanne S. Taillefer (National Study Coordinator for the
Canadian Scleroderma Research Group), Sofia Vargas, Sonia
Garcı́a, and Gema Robledo. We also thank the Scleroderma Foun-
dation, the Spanish Scleroderma Patient Group, the Canadian
Scleroderma Patient Group, the Federation of European Sclero-
derma Associations, National DNA Bank Carlos III (University of
Salamanca), the European League against Rheumatism Sclero-
derma Trials and Research group, the German Network of Systemic
Sclerosis, and the affected individuals, friends, spouses, and others
who generously provided the samples for these studies.},
publisher = {Elsevier},
title = {Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis},
doi = {10.1016/j.ajhg.2013.12.002},
author = {Mayes, Maureen D. and Bossini Castillo, Lara María and Alarcón Riquelme, Marta Eugenia and Martín Ibáñez, Javier},
}